We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Heart Test Laboratories Inc (HSCS) USD0.001

Sell:$3.42 Buy:$3.46 Change: $0.30 (9.20%)
Market closed |  Prices as at close on 16 August 2024 | Switch to live prices |
Sell:$3.42
Buy:$3.46
Change: $0.30 (9.20%)
Market closed |  Prices as at close on 16 August 2024 | Switch to live prices |
Sell:$3.42
Buy:$3.46
Change: $0.30 (9.20%)
Market closed |  Prices as at close on 16 August 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Heart Test Laboratories, Inc., doing business as, HeartSciences is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of AI-ECG algorithms and intends to provide these AI-ECG algorithms on a device agnostic cloud-based solution as well as an ECG hardware platform. The Company applies AI-machine learning to the signal processed ECG signal to develop an algorithm designed to detect impaired cardiac relaxation, or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction. The Company's product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test.

Contact details

Address:
550 Reserve St, Suite 360
SOUTHLAKE
76092
United States
Telephone:
+1 (682) 2377781
Website:
https://heartsciences.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HSCS
ISIN:
US42254E3027
Market cap:
$2.85 million
Shares in issue:
855,966
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Andrew Simpson
    Chairman of the Board, President, Chief Executive Officer
  • Danielle Watson
    Chief Financial Officer, Treasurer
  • Mark Hilz
    Chief Operating Officer, Secretary, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.